Hakutulokset - City of Boston
-
1
Residents of Late Nineteenth-Century Port Districts: A Comparative Dataset from Antwerp and Boston, 1880–1900
Julkaistu 2025-06-01Aiheet: “…port cities…”This data paper presents a historical dataset that provides a comparative snapshot of the social composition of two transatlantic port districts during a period of significant urban and maritime transformation. It documents over 5,000 individuals residing in the main commercial thoroughfares of Antw...
Hae kokoteksti
Artikkeli -
2
-
3
A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030
Julkaistu 2025-07-01“…Kelsey S Lau-Min,1 Thomas Abrams,2 Andrea Bullock,3 Alyson Kaplan,4 Leslie Salas Karnes,5 Mark W Kennedy,6 Christina A LeBedis,7 Ming V Lin,8 Nadine Jackson McCleary,2 Shirin Sioshansi,9 Emma Voligny,2 Elizabeth Paige Walsh,10 Christopher R Manz2 On behalf of HCC-CARE1Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; 3Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA; 4Abdominal Transplant Institute, Tufts Medical Center, Boston, MA, USA; 5Department of Clinical Health Affairs, Massachusetts League of Community Health Centers, Boston, MA, USA; 6Boston Public Health Commission, Boston, MA, USA; 7Department of Radiology, Boston Medical Center, Boston, MA, USA; 8Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA, USA; 9Department of Radiation Oncology, UMass Memorial Medical Center, Worcester, MA, USA; 10Department of Medicine, Massachusetts General Hospital, Boston, MA, USACorrespondence: Christopher R Manz, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA, Email Christopher_Manz@dfci.harvard.eduAbstract: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality in the United States. …”Kelsey S Lau-Min,1 Thomas Abrams,2 Andrea Bullock,3 Alyson Kaplan,4 Leslie Salas Karnes,5 Mark W Kennedy,6 Christina A LeBedis,7 Ming V Lin,8 Nadine Jackson McCleary,2 Shirin Sioshansi,9 Emma Voligny,2 Elizabeth Paige Walsh,10 Christopher R Manz2 On behalf of HCC-CARE1Division of Hematology/Oncology...
Hae kokoteksti
Artikkeli -
4
-
5
-
6
-
7
Solar activity and mortality: a meta-analysis of six cities in the Eastern Mediterranean and Middle East
Julkaistu 2025-08-01Hae kokotekstiBackground: Solar and geomagnetic activity have been linked to a multitude of impacts on human health including cardiovascular disease (CVD), and total non-accidental mortality. However, this has not been assessed in the Eastern Mediterranean Region or the Middle East. Our study aimed to assess the...
Artikkeli -
8
-
9
-
10
-
11
-
12
-
13
Long-read sequencing is required for precision diagnosis of incontinentia pigmenti
Julkaistu 2025-07-01Hae kokotekstiSummary: Incontinentia pigmenti (IP) is caused by loss-of-function variants in IKBKG, with molecular genetic diagnosis complicated by a pseudogene. We describe seven individuals from three families with IP but negative clinical genetic testing in whom long-read sequencing identified causal variants,...
Artikkeli -
14
Strengthening Faculty Development through Regional and Global Collaboration: An Innovative Virtual Program in Cambodia
Julkaistu 2025-06-01Hae kokotekstiBackground: Cambodia faces significant shortages of qualified physicians and skilled faculty, posing challenges for both medical training and educational reform. Innovative faculty development initiatives are essential in resource‑limited settings to address these gaps and support broader reforms. O...
Artikkeli -
15
-
16
ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER — THE ROLE OF FULVESTRANT
Julkaistu 2014-09-01Hae kokotekstiFor many years, tamoxifen has been the _gold standard_ amongst anti-oestrogen therapies for breast cancer. However, the selective aro- matase inhibitors (AIs), anastrozole, letrozole and exemestane, have demonstrated advantages over tamoxifen as first-line treatments for advanced disease. Anastrozol...
Artikkeli -
17
Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single‐Session, Telehealth Intervention for Patients With Cancer‐Related Pain
Julkaistu 2025-05-01Hae kokotekstiABSTRACT Introduction Patients with cancer have limited access to comprehensive pain treatment. We developed a 90‐min, single‐session, telehealth, interdisciplinary intervention that combines cancer‐specific medical education and behavioral pain treatment. We evaluated the intervention's prelim...
Artikkeli -
18
Mito-Kaede photoactivation and chase experiment for mitophagy: mitophagy flux response toward various stimulations
Julkaistu 2025-04-01Hae kokotekstiMitophagy, a crucial mitochondrial quality control system for cellular stress adaptation, is a key focus in pathophysiology and drug discovery. Developing a simple and versatile mitophagy flux assay is vital for advancing our understanding of cellular responses. Addressing a gap in systematic method...
Artikkeli -
19
Updates to Administrative Coding Systems Limits Longitudinal Study of Patients with Congenital Heart Disease
Julkaistu 2025-08-01 Hae kokoteksti
Artikkeli -
20
